Intravenous thyrotropin releasing hormone vs placeboAdverse events related to treatment · children with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 9 participantsVery low